LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 GSK1059615
10.0
uM
LJP5
 0.1179 0.0134 -0.2782 0.0279
BT-20 GSK1059615
10.0
uM
LJP6
 0.1171 0.0213 -0.2806 0.0543
BT-20 GSK1904529A
10.0
uM
LJP6
 0.9812 0.0153 0.9719 0.0230
BT-20 Omipalisib
10.0
uM
LJP6
 0.1465 0.0295 -0.2373 0.0545
BT-20 GSK 690693
10.0
uM
LJP5
 0.5317 0.0224 0.3221 0.0263
BT-20 GW843682X
10.0
uM
LJP6
 0.3027 0.0774 -0.0150 0.1330
BT-20 HG-5-113-01
10.0
uM
LJP5
 0.2315 0.0175 -0.1148 0.0478
BT-20 HG-5-88-01
10.0
uM
LJP6
 0.5451 0.0128 0.3415 0.0076
BT-20 Imatinib
10.0
uM
LJP6
 0.9636 0.0311 0.9490 0.0445
BT-20 JNK-9L
10.0
uM
LJP6
 0.2046 0.0145 -0.1534 0.0430
BT-20 JW-7-24-1
10.0
uM
LJP6
 0.2978 0.0566 -0.0150 0.0657
BT-20 Lapatinib
10.0
uM
LJP6
 0.7835 0.0748 0.6904 0.1032
BT-20 LDN-193189
10.0
uM
LJP5
 0.0950 0.0213 -0.3104 0.0122
BT-20 Linifanib
10.0
uM
LJP6
 0.6451 0.1613 0.4950 0.2277
BT-20 Linsitinib
10.0
uM
LJP5
 0.8453 0.0268 0.7769 0.0362
BT-20 Mitoxantrone
10.0
uM
LJP5
 0.1095 0.0433 -0.2905 0.0659
BT-20 Mitoxantrone
10.0
uM
LJP6
 0.1224 0.0350 -0.2708 0.0425
BT-20 MK2206
10.0
uM
LJP6
 0.3618 0.1041 0.0810 0.1343
BT-20 Neratinib
10.0
uM
LJP5
 0.4881 0.0574 0.2608 0.0711
BT-20 Nilotinib
10.0
uM
LJP5
 0.3203 0.0287 0.0150 0.0451
BT-20 Nintedanib
10.0
uM
LJP6
 0.6130 0.0579 0.4424 0.0737
BT-20 NU7441
10.0
uM
LJP5
 0.4652 0.0723 0.2291 0.0907
BT-20 Dactolisib
10.0
uM
LJP5
 0.3662 0.0057 0.0812 0.0239
BT-20 NVP-TAE684
10.0
uM
LJP6
 0.3893 0.1083 0.1211 0.1424
BT-20 Palbociclib
10.0
uM
LJP6
 0.4169 0.0069 0.1553 0.0133